Pramipexole Dihydrochloride Class Action
Pramipexole Dihydrochloride is a drug prescribed for treatment of Parkinson’s Disease and Restless Leg Syndrome and has been associated with impulse control disorders and compulsive behaviours such as gambling and overeating.
Merchant Law Group LLP is pursuing a class action against the makers of Teva-Pramipexole, Co-Pramipexole, and PMS-Pramipexole only on behalf of applicable patients who took these drugs and suffered impulse control disorders or new compulsive behaviours. If you would like to stay informed of the progress of action, please provide your contact information below. Please note, our class action only concerns the three drugs mentioned above.
PLEASE NOTE – Our law firm cannot pursue any legal claims or answer any inquiries regarding Mirapex. Any legal claims regarding Mirapex are governed by a previous Canadian class action settlement, the details of which are explained at http://www.parkinsonalberta.ca/settlement-of-the-mirapex-class-action-notice-to-users-of-mirapex
Merchant Law Group LLP has 10 offices across Canada, with lawyers practising law in six provinces. Merchant Law Group LLP and Tony Merchant, Q.C. are well known for pursuing class action lawsuits in Canada including litigation regarding Winners/HomeSense, Various Cellular Phone Fees, BCE Dividends, GM Gasket Manifolds, Hip Implants, Lead Paint in Toys (and similar consumer products), Maple Leaf, Celebrex/Bextra, Vioxx, Sony, Residential Schools and various other cases. Tony Merchant, Q.C. is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. Tony Merchant, Q.C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M.L.A.)